Related Experiment Video
Updated: Jul 2, 2025
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments
Jianan Xu1, Lin Tian2, Wenlong Qi2
1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine.
Abstract:
With the global incidence of non-small cell lung cancer (NSCLC) on the rise, the development of innovative treatment strategies is increasingly vital. This review underscores the pivotal role of precision medicine in transforming NSCLC management, particularly through the integration of genomic and epigenomic insights to enhance treatment outcomes for patients. We focus on the identification of key gene mutations and examine the evolution and impact of targeted therapies. These therapies have shown encouraging results in improving survival rates and quality of life. Despite numerous gene mutations being identified in association with NSCLC, targeted treatments are available for only a select few. This paper offers an exhaustive analysis of the pathogenesis of NSCLC and reviews the latest advancements in targeted therapeutic approaches. It emphasizes the ongoing necessity for research and development in this domain. In addition, we discuss the current challenges faced in the clinical application of these therapies and the potential directions for future research, including the identification of novel targets and the development of new treatment modalities.
Insights
Precision medicine, integrating genomic insights, is revolutionizing non-small cell lung cancer (NSCLC) treatment. Targeted therapies offer improved outcomes, but further research is needed for broader application.
Area of Science:
- Oncology
- Genomics
- Precision Medicine
Background:
- Global incidence of non-small cell lung cancer (NSCLC) is increasing.
- Innovative treatment strategies are crucial for managing NSCLC.
- Precision medicine offers a transformative approach to NSCLC care.
Purpose of the Study:
- To review the role of precision medicine in NSCLC management.
- To analyze the impact of genomic and epigenomic insights on treatment outcomes.
- To discuss advancements in targeted therapies for NSCLC.
Main Methods:
- Literature review focusing on NSCLC pathogenesis.
- Analysis of key gene mutations and their targeted therapies.
- Examination of current challenges and future research directions.
Main Results:
- Genomic and epigenomic insights are pivotal for enhancing NSCLC treatment.
- Targeted therapies have shown significant improvements in survival and quality of life.
- Available targeted treatments cover only a subset of identified NSCLC mutations.
Conclusions:
- Precision medicine, driven by genetic discoveries, is reshaping NSCLC treatment paradigms.
- Continued research is essential for identifying novel targets and developing new therapeutic modalities.
- Addressing clinical application challenges is key to maximizing the benefits of targeted NSCLC therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...